Next Article in Journal
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin
Previous Article in Journal
The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors
Previous Article in Special Issue
CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Notch Signaling in Health and Disease

by
Paola Maura Tricarico
1,* and
Sergio Crovella
2
1
Institute for Maternal and Child Health—IRCCS “Burlo Garofolo”, Department of Advanced Diagnostics, 34137 Trieste, Italy
2
Laboratory of Animal Research Center (LARC), Qatar University, Doha P.O. Box 2713, Qatar
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(22), 16113; https://doi.org/10.3390/ijms242216113
Submission received: 26 October 2023 / Accepted: 6 November 2023 / Published: 9 November 2023
(This article belongs to the Special Issue Notch Signaling in Health and Disease)
The Notch signaling pathway, a vital and evolutionarily conserved regulator of cellular processes, intricately shapes both health and disease. In the realm of health, Notch signaling assumes a pivotal role in the skin homeostasis, orchestrating primary growth arrest and progressive keratinocyte differentiation processes [1]. Moreover, Notch signaling is also critical in other adult organs and tissues such as the liver, intestine, hematopoietic system, and skeletal muscle.
Its involvement in immune cell homeostasis and organ-specific immune responses accentuates its overarching significance in overall immune function [2]. Moreover, the pathway contributes to the integrity of the vasculature, the development of smooth muscle cells, and intricate processes such as osteogenic differentiation, highlighting its versatile role in maintaining physiological balance.
Conversely, dysregulation of Notch signaling is implicated in an array of diseases. In cancer, aberrant Notch activation is intricately linked to tumor initiation, progression, and chemoresistance across various malignancies [3]. Cardiovascular disorders, exemplified by myocardial infarction, showcase the cardioprotective effects of Notch signaling [4], while neurological conditions like Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) underscore its role in hereditary strokes [5]. In essence, unraveling the nuanced dynamics of Notch signaling is paramount for understanding the molecular underpinnings of diseases and harnessing its therapeutic potential. The multifaceted involvement of Notch signaling in health and disease underscores its intricate nature, positioning it as a promising avenue for targeted interventions and personalized medicine.
This Special Issue titled “Notch Signaling in Health and Disease” delves into the diverse roles of the Notch signaling pathway in various physiological and pathological contexts. The manuscripts included in this compilation shed light on the intricate involvement of Notch signaling in myocardial infarction, immune responses, oral squamous cell carcinoma, CADASIL, vascular smooth muscle cells, osteogenic differentiation, renal vascular response, ovarian cancer, colon adenocarcinoma, glioblastoma, and epithelial ovarian cancer.
The review “Myocardial Infarction and Cardio protection” emphasizes the cardioprotective effects of Notch signaling in myocardial infarction, elucidating its role in reducing oxidative stress, preventing apoptosis, regulating inflammation, containing fibrosis, facilitating tissue revascularization, and orchestrating the proliferation and differentiation of cardiomyocytes. Notch signaling emerges as a potential therapeutic target for enhancing cardiac recovery post-myocardial infarction.
The review “Notch Signaling in Immune Responses and Sepsis” explores the dual role of Notch signaling in immune cell differentiation and its impact on immune signals. Focusing on conditions like sepsis, it navigates through the modulation of organ-specific immune responses. This review raises prospects for manipulating the Notch signaling pathway as a future therapeutic strategy for inflammatory diseases.
The research article “Notch Signaling in Oral Squamous Cell Carcinoma (OSCC)”, investigates the inhibition of Notch signaling in OSCC. The authors reveal its crucial role in promoting cell growth, cell cycle progression, migration, and invasion. The findings suggest the potential use of Notch signaling inhibitors as adjuvant treatments in OSCC patients.
“CADASIL and Blood Biomarkers” is focused on CADASIL, a hereditary stroke disorder, which is associated with mutations in the NOTCH3 gene. In this research article, authors introduce blood biomarkers related to the Notch signaling pathway, providing a basis for further research on their clinical utility in CADASIL and related diseases.
Focusing on the stability of CSL proteins that is central to Notch signal transduction, “Regulation of Notch Components” revealed conserved mechanisms of CSL protein turnover across species. The findings suggest that turnover of CSL proteins may regulate Notch signaling output at the transcriptional level.
Examining the indirect immobilization of Jagged-1 and its effects on osteogenic differentiation, the research article “Jagged-1 in Osteogenic Differentiation” delves into the proteomic profiles of dental pulp stem cells. The study suggests that Jagged-1 induces osteogenic differentiation through the regulation of proteins in the membrane compartment.
The research article “Renal Vascular Response and Notch3” investigates Notch3’s role in renal vascular response. The authors identified its essential role in excitation–contraction coupling and vascular-tone regulation in the kidney. Notch3 deficiency led to altered vascular reactivity, emphasizing its significance in renal physiology.
“Diagnostic Biomarkers in Ovarian Cancer” explored the dysregulation of the Notch pathway in ovarian cancer. This pilot study identified a panel of genes, including ARID1A, CTNNB1, FBXW7, and PPP2R1A, as potential diagnostic biomarkers for ovarian cancer.
“Notch4 in Colon Adenocarcinoma” investigated the clinical application of Notch4 in colon adenocarcinoma. This research article highlights its role as a potential prognostic marker in patients with this malignancy.
The research article “Combating Chemoresistance in Ovarian Cancer” addressed chemoresistance in ovarian cancer. The authors revealed that the inhibition of Notch signaling, in combination with resveratrol, can reverse the transformation of mesenchymal phenotypes to epithelial-like phenotypes, which affect invasion and stemness.
“CD109 in Epithelial Ovarian Cancer” unraveled the role of CD109 in epithelial ovarian cancer. and uncovered its positive correlation with drug resistance. The study suggests that CD109 induces drug resistance through the STAT3-NOTCH1 signaling axis.
This Special Issue provides a comprehensive overview of the diverse facets of Notch signaling, from cardiovascular health to cancer biology [6] emphasizing its potential as a therapeutic target in various diseases [7]. The insights derived from these manuscripts contribute to our understanding of the intricate roles played by Notch signaling in health and disease, paving the way for future research and clinical applications.

Author Contributions

P.M.T. and S.C. designed and prepared the manuscript. All authors received and reviewed the final draft. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gratton, R.; Tricarico, P.M.; Moltrasio, C.; Lima Estevão de Oliveira, A.S.; Brandão, L.; Marzano, A.V.; Zupin, L.; Crovella, S. Pleiotropic Role of Notch Signaling in Human Skin Diseases. Int. J. Mol. Sci. 2020, 21, 4214. [Google Scholar] [CrossRef] [PubMed]
  2. Zhou, B.; Lin, W.; Long, Y.; Yang, Y.; Zhang, H.; Wu, K.; Chu, Q. Notch signaling pathway: Architecture, disease, and therapeutics. Signal Transduct. Target. Ther. 2022, 7, 95. [Google Scholar] [CrossRef] [PubMed]
  3. Ferreira, A.; Aster, J.C. Notch signaling in cancer: Complexity and challenges on the path to clinical translation. Semin. Cancer Biol. 2022, 85, 95–106. [Google Scholar] [CrossRef] [PubMed]
  4. Peng, M.L.; Fu, Y.; Wu, C.W.; Zhang, Y.; Ren, H.; Zhou, S.S. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy. Front. Endocrinol. 2022, 13, 907757. [Google Scholar] [CrossRef] [PubMed]
  5. Mizuno, T.; Mizuta, I.; Watanabe-Hosomi, A.; Mukai, M.; Koizumi, T. Clinical and Genetic Aspects of CADASIL. Front. Aging Neurosci. 2020, 12, 91. [Google Scholar] [CrossRef] [PubMed]
  6. Li, X.; Yan, X.; Wang, Y.; Kaur, B.; Han, H.; Yu, J. The Notch signaling pathway: A potential target for cancer immunotherapy. J. Hematol. Oncol. 2023, 16, 45. [Google Scholar] [CrossRef] [PubMed]
  7. Franciosa, G.; Smits, J.G.A.; Minuzzo, S.; Martinez-Val, A.; Indraccolo, S.; Olsen, J.V. Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures. Nat. Commun. 2021, 12, 2507. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tricarico, P.M.; Crovella, S. Notch Signaling in Health and Disease. Int. J. Mol. Sci. 2023, 24, 16113. https://doi.org/10.3390/ijms242216113

AMA Style

Tricarico PM, Crovella S. Notch Signaling in Health and Disease. International Journal of Molecular Sciences. 2023; 24(22):16113. https://doi.org/10.3390/ijms242216113

Chicago/Turabian Style

Tricarico, Paola Maura, and Sergio Crovella. 2023. "Notch Signaling in Health and Disease" International Journal of Molecular Sciences 24, no. 22: 16113. https://doi.org/10.3390/ijms242216113

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop